Zentalis Pharmaceuticals (NASDAQ:ZNTL) Stock Price Up 3.6%

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) rose 3.6% during trading on Wednesday . The stock traded as high as $18.28 and last traded at $18.12. Approximately 284,046 shares traded hands during trading, a decline of 49% from the average daily volume of 559,839 shares. The stock had previously closed at $17.49. Wall Street Analyst […]

Related Keywords

Melissab Epperly ,Stifel Nicolaus ,Nasdaq ,Zentalis Pharmaceuticals Stock Performance ,Sofinnova Investments Inc ,Securities Exchange Commission ,Zentalis Pharmaceuticals Inc ,Insider Activity At Zentalis Pharmaceuticals ,Zentalis Pharmaceuticals ,News Ratings For Zentalis Pharmaceuticals Daily ,Barclays Plc ,Zentalis Pharmaceuticals Company Profile ,Institutional Investors Weigh In On Zentalis Pharmaceuticals ,Ensign Peak Advisors Inc ,Eventide Asset Management ,Evergreen Capital Management ,Get Rating ,President Cam Gallagher ,Exchange Commission ,Asset Management ,Peak Advisors Inc ,Zentalis Pharmaceuticals Daily ,Nasdaq Zntl ,Zntl ,Medical ,Stocks ,Technicals ,